Christopher (Chris) Staab is a seasoned professional with a career spanning over two decades in the fields of quality management, regulatory affairs, and leadership within the healthcare and medical device industry. His extensive experience and unwavering commitment to excellence have made him a notable figure in the industry.

In his current role as President and Quality and Regulatory Affairs Consultant at Regulatory and Technical Associates, Chris is driving the strategic direction of the company. His hybrid work approach allows him to adapt to evolving industry trends while delivering top-notch consulting services in the highly dynamic regulatory environment. He is available to bring his wealth of expertise to support quality and regulatory activities for both large and small companies.

Chris’ dedication to ethical research practices is evident in his role as President and Investigational Review Board (IRB) Chairman at the Allendale Investigational Review Board (AIRB). In this capacity, he plays a crucial role in ensuring the ethical conduct of research studies, a responsibility that aligns seamlessly with his commitment to upholding the highest standards of quality and compliance.

His prior role as Vice President of Global Quality at CooperSurgical demonstrates his executive leadership prowess, where he navigates the complexities of global quality management and regulatory with finesse and an unwavering commitment to delivering excellence. During his tenure at Medtronic, where he spent over a decade, Chris honed his skills in supplier quality management and quality engineering, contributing significantly to the company's reputation for delivering safe and high-quality medical devices.

Chris' educational journey began with a Bachelor of Science degree in Biology from Roger Williams University. His academic achievements, coupled with his practical experience, serve as a solid foundation for his successful career. He further enhanced his knowledge base with a Master of Business Administration (MBA) from Capella University, specializing in Business Administration and Management, showcasing his commitment to continuous learning and professional growth. He is currently working towards his Doctorate in Public Health (DpH), also from Capella University with an expected graduation in 2025.

In conclusion, Chris’ impressive career trajectory, from hands-on quality management to executive leadership, underscores his unwavering dedication to quality, compliance, and ethical standards within the healthcare and regulatory landscape. His holistic approach, combined with a strong academic background, positions him as a trusted authority and invaluable contributor to the fields of quality and regulatory affairs. Chris’ tireless pursuit of excellence ensures that he remains at the forefront of shaping industry best practices and driving innovation in the ever-evolving healthcare sector. He is readily available to leverage his expertise as a consultant, supporting quality and regulatory activities for both large corporations and small enterprises alike.